Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982600207> ?p ?o ?g. }
- W1982600207 endingPage "143.e15" @default.
- W1982600207 startingPage "134" @default.
- W1982600207 abstract "Purpose Cancer patients who undergo radiotherapy remain at life-long risk of radiation-induced injury to normal tissues. We conducted a randomized, controlled, double-blind crossover trial with long-term follow-up to evaluate the effectiveness of hyperbaric oxygen for refractory radiation proctitis. Methods and Materials Patients with refractory radiation proctitis were randomized to hyperbaric oxygen at 2.0 atmospheres absolute (Group 1) or air at 1.1 atmospheres absolute (Group 2). The sham patients were subsequently crossed to Group 1. All patients were re-evaluated by an investigator who was unaware of the treatment allocation at 3 and 6 months and Years 1–5. The primary outcome measures were the late effects normal tissue-subjective, objective, management, analytic (SOMA-LENT) score and standardized clinical assessment. The secondary outcome was the change in quality of life. Results Of 226 patients assessed, 150 were entered in the study and 120 were evaluable. After the initial allocation, the mean SOMA-LENT score improved in both groups. For Group 1, the mean was lower (p = 0.0150) and the amount of improvement nearly twice as great (5.00 vs. 2.61, p = 0.0019). Similarly, Group 1 had a greater portion of responders per clinical assessment than did Group 2 (88.9% vs. 62.5%, respectively; p = 0.0009). Significance improved when the data were analyzed from an intention to treat perspective (p = 0.0006). Group 1 had a better result in the quality of life bowel bother subscale. These differences were abolished after the crossover. Conclusion Hyperbaric oxygen therapy significantly improved the healing responses in patients with refractory radiation proctitis, generating an absolute risk reduction of 32% (number needed to treat of 3) between the groups after the initial allocation. Other medical management requirements were discontinued, and advanced interventions were largely avoided. Enhanced bowel-specific quality of life resulted. Cancer patients who undergo radiotherapy remain at life-long risk of radiation-induced injury to normal tissues. We conducted a randomized, controlled, double-blind crossover trial with long-term follow-up to evaluate the effectiveness of hyperbaric oxygen for refractory radiation proctitis. Patients with refractory radiation proctitis were randomized to hyperbaric oxygen at 2.0 atmospheres absolute (Group 1) or air at 1.1 atmospheres absolute (Group 2). The sham patients were subsequently crossed to Group 1. All patients were re-evaluated by an investigator who was unaware of the treatment allocation at 3 and 6 months and Years 1–5. The primary outcome measures were the late effects normal tissue-subjective, objective, management, analytic (SOMA-LENT) score and standardized clinical assessment. The secondary outcome was the change in quality of life. Of 226 patients assessed, 150 were entered in the study and 120 were evaluable. After the initial allocation, the mean SOMA-LENT score improved in both groups. For Group 1, the mean was lower (p = 0.0150) and the amount of improvement nearly twice as great (5.00 vs. 2.61, p = 0.0019). Similarly, Group 1 had a greater portion of responders per clinical assessment than did Group 2 (88.9% vs. 62.5%, respectively; p = 0.0009). Significance improved when the data were analyzed from an intention to treat perspective (p = 0.0006). Group 1 had a better result in the quality of life bowel bother subscale. These differences were abolished after the crossover. Hyperbaric oxygen therapy significantly improved the healing responses in patients with refractory radiation proctitis, generating an absolute risk reduction of 32% (number needed to treat of 3) between the groups after the initial allocation. Other medical management requirements were discontinued, and advanced interventions were largely avoided. Enhanced bowel-specific quality of life resulted." @default.
- W1982600207 created "2016-06-24" @default.
- W1982600207 creator A5016067447 @default.
- W1982600207 creator A5024595673 @default.
- W1982600207 creator A5025001972 @default.
- W1982600207 creator A5037939415 @default.
- W1982600207 creator A5042879766 @default.
- W1982600207 creator A5060003139 @default.
- W1982600207 creator A5072770733 @default.
- W1982600207 creator A5074349192 @default.
- W1982600207 creator A5078704660 @default.
- W1982600207 creator A5087604575 @default.
- W1982600207 creator A5087831912 @default.
- W1982600207 date "2008-09-01" @default.
- W1982600207 modified "2023-10-10" @default.
- W1982600207 title "Hyperbaric Oxygen Treatment of Chronic Refractory Radiation Proctitis: A Randomized and Controlled Double-Blind Crossover Trial With Long-Term Follow-Up" @default.
- W1982600207 cites W1489099843 @default.
- W1982600207 cites W1512672311 @default.
- W1982600207 cites W196404944 @default.
- W1982600207 cites W1975048397 @default.
- W1982600207 cites W1981151768 @default.
- W1982600207 cites W1989134488 @default.
- W1982600207 cites W1991172377 @default.
- W1982600207 cites W2005769276 @default.
- W1982600207 cites W2007402319 @default.
- W1982600207 cites W2016637530 @default.
- W1982600207 cites W2016982738 @default.
- W1982600207 cites W2017880061 @default.
- W1982600207 cites W2020391654 @default.
- W1982600207 cites W2020624844 @default.
- W1982600207 cites W2032965196 @default.
- W1982600207 cites W2037880159 @default.
- W1982600207 cites W2044507532 @default.
- W1982600207 cites W2049386837 @default.
- W1982600207 cites W2059980450 @default.
- W1982600207 cites W2074386077 @default.
- W1982600207 cites W2075070831 @default.
- W1982600207 cites W2075293182 @default.
- W1982600207 cites W2078357702 @default.
- W1982600207 cites W2093640117 @default.
- W1982600207 cites W2093990737 @default.
- W1982600207 cites W2108662268 @default.
- W1982600207 cites W2110446337 @default.
- W1982600207 cites W2124550370 @default.
- W1982600207 cites W2132118893 @default.
- W1982600207 cites W2133508788 @default.
- W1982600207 cites W2136139632 @default.
- W1982600207 cites W2137282952 @default.
- W1982600207 cites W2312710661 @default.
- W1982600207 cites W2330651639 @default.
- W1982600207 cites W2789386510 @default.
- W1982600207 cites W4251594412 @default.
- W1982600207 doi "https://doi.org/10.1016/j.ijrobp.2007.12.048" @default.
- W1982600207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18342453" @default.
- W1982600207 hasPublicationYear "2008" @default.
- W1982600207 type Work @default.
- W1982600207 sameAs 1982600207 @default.
- W1982600207 citedByCount "202" @default.
- W1982600207 countsByYear W19826002072012 @default.
- W1982600207 countsByYear W19826002072013 @default.
- W1982600207 countsByYear W19826002072014 @default.
- W1982600207 countsByYear W19826002072015 @default.
- W1982600207 countsByYear W19826002072016 @default.
- W1982600207 countsByYear W19826002072017 @default.
- W1982600207 countsByYear W19826002072018 @default.
- W1982600207 countsByYear W19826002072019 @default.
- W1982600207 countsByYear W19826002072020 @default.
- W1982600207 countsByYear W19826002072021 @default.
- W1982600207 countsByYear W19826002072022 @default.
- W1982600207 countsByYear W19826002072023 @default.
- W1982600207 crossrefType "journal-article" @default.
- W1982600207 hasAuthorship W1982600207A5016067447 @default.
- W1982600207 hasAuthorship W1982600207A5024595673 @default.
- W1982600207 hasAuthorship W1982600207A5025001972 @default.
- W1982600207 hasAuthorship W1982600207A5037939415 @default.
- W1982600207 hasAuthorship W1982600207A5042879766 @default.
- W1982600207 hasAuthorship W1982600207A5060003139 @default.
- W1982600207 hasAuthorship W1982600207A5072770733 @default.
- W1982600207 hasAuthorship W1982600207A5074349192 @default.
- W1982600207 hasAuthorship W1982600207A5078704660 @default.
- W1982600207 hasAuthorship W1982600207A5087604575 @default.
- W1982600207 hasAuthorship W1982600207A5087831912 @default.
- W1982600207 hasConcept C121332964 @default.
- W1982600207 hasConcept C126322002 @default.
- W1982600207 hasConcept C141071460 @default.
- W1982600207 hasConcept C142424586 @default.
- W1982600207 hasConcept C142724271 @default.
- W1982600207 hasConcept C159110408 @default.
- W1982600207 hasConcept C168563851 @default.
- W1982600207 hasConcept C204787440 @default.
- W1982600207 hasConcept C27081682 @default.
- W1982600207 hasConcept C2777789768 @default.
- W1982600207 hasConcept C2779134260 @default.
- W1982600207 hasConcept C2779810446 @default.
- W1982600207 hasConcept C2779951463 @default.
- W1982600207 hasConcept C2780479503 @default.
- W1982600207 hasConcept C2994405533 @default.
- W1982600207 hasConcept C509974204 @default.